drugset / Trial / NCT06243835
A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults
Phase 1
Terminated
16 enrolled
Lohocla Research Corporation
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study is to test Kindolor in healthy adults. The main questions it aims to answer are: * What is the safe dose of Kindolor in healthy volunteers? * How is Kindolor metabolized by the human body? Participants will undergo medical tests before and after receiving Kindolor or a placebo to see if there is any difference between the groups.
Timeline
- Start
- 2024-04-21
- Primary completion
- 2024-11-22
- Completion
- 2025-02-27
Outcome
Outcome not reported
Stopped: “Terminated by sponsor due to low drug bioavailability; no safety concerns were noted.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kindolor | Unknown | 100 mg | — |
| Subject | Kindolor | Unknown | 300 mg | — |